It is a peptide that may affect growth hormone signaling, recovery perception, sleep, appetite, glucose-related factors, and body composition goals
Food and Drug Administration (FDA) and should be approached with caution under qualified medical guidance
When the impact is particularly severe it can lead to depression
Recently, it has been popularly labeled "natures Ozempic," referencing its claimed similarities to the pharmaceutical agent Ozempic (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist approved for managing type 2 diabetes mellitus and facilitating weight loss
Patoulias D, Doumas M, Papadopoulos C (2022) Meta-analysis assessing the effect of tirzepatide on the risk for atrial fibrillation in patients with type 2 diabetes mellitus